Home
/

What is a Platelet-to-Lymphocyte Ratio Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

PLR (platelet-to-lymphocyte ratio) is a CBC-derived marker of systemic inflammation and immuno-hemostatic balance, calculated by dividing platelet count by lymphocyte count. In healthy adults, PLR typically falls in the low hundreds; elevated values reflect inflammation from infection, surgery, chronic disease, or smoking and have been associated with worse cardiovascular and cancer outcomes, while low values may indicate platelet-poor or lymphocyte-rich states.

Read more →
Table of contents

The platelet-to-lymphocyte ratio explained

The platelet-to-lymphocyte ratio (PLR) is a derived biomarker calculated from a routine blood count. It compares the number of platelets to the number of lymphocytes circulating in your blood. Platelets (thrombocytes) are small cell fragments made in the bone marrow from megakaryocytes, ready to plug leaks and release inflammatory signals. Lymphocytes are white blood cells of the adaptive immune system—mainly T cells, B cells, and natural killer cells—formed in the bone marrow and matured in lymphoid organs, patrolling blood and tissues.

PLR captures the biologic balance between clotting and inflammation on one side and immune surveillance and regulation on the other. Because platelets participate in hemostasis and amplify inflammatory signaling, and lymphocytes coordinate targeted immune responses, their ratio offers a compact readout of systemic inflammatory tone and stress (immuno-hemostatic status). Clinically and in research, PLR is used as a general marker of the body's response to injury, infection, or disease burden, integrating two fundamental arms of host defense. It does not diagnose a specific condition; instead, it reflects how the blood’s clotting machinery and immune cells are “set” at a given moment.

PLR as a window into systemic inflammation

Platelet-to-Lymphocyte Ratio (PLR) links two core systems: platelets that drive clotting and inflammation, and lymphocytes that power adaptive immunity. By comparing them, PLR acts as a snapshot of the body’s balance between pro‑thrombotic/inflammatory activity and immune competence, and it has been studied as a risk marker in cardiovascular disease, infections, autoimmune conditions, and cancer outcomes.

Big picture: PLR integrates hemostasis and immune tone. Interpreted alongside CBC indices, CRP, and clinical findings, it helps frame long-term risks tied to chronic inflammation, thrombosis, infection susceptibility, and tissue repair capacity.

Low, in-range, and high PLR signals

There is no universal reference range, but in healthy adults PLR often falls in the low hundreds. Values near the middle tend to reflect steadier physiology; extremes suggest imbalance that warrants context from the full blood count and clinical picture.

When PLR is low, it usually reflects fewer platelets, more lymphocytes, or both. Platelet-poor states can show up as easy bruising, nosebleeds, petechiae, or heavy periods, and may signal marrow stress, immune thrombocytopenia, liver/spleen sequestration, or medication effects. Lymphocyte-predominant states commonly follow viral infections or certain chronic immune conditions and can bring fatigue, low-grade fevers, or swollen glands. Children often have lower PLR because lymphocytes are naturally higher; women may sit slightly higher than men due to higher platelet counts.

When PLR is high, inflammation or stress tilts the ratio via higher platelets or lower lymphocytes—seen with acute illness, surgery, glucocorticoids, iron deficiency, chronic inflammatory disease, or smoking. Systems-wise, this pattern tracks with a pro‑inflammatory, pro‑thrombotic milieu and, in research, associates with worse prognosis in heart disease and some cancers. In pregnancy, physiologic blood count shifts can nudge PLR, especially later gestation.

Conditions and meds that nudge PLR

Notes: Interpretation depends on context—acute infections, recent exertion, pregnancy trimester shifts, aging, smoking, corticosteroids or immunosuppressants, chemotherapy, and splenectomy all alter counts. The ratio is reliable when both platelet and lymphocyte results are internally consistent and not at extreme outliers.

Making sense of your PLR result

What a Platelet-to-Lymphocyte Ratio blood test tells you

The platelet-to-ymphocyte ratio (PLR) is calculated from a standard complete blood count. It compares clotting cells (platelets) to adaptive immune cells (lymphocytes). This ratio is a practical summary of inflammatory tone and stress physiology, linking blood coagulation readiness, tissue repair, and immune surveillance with risks related to cardiovascular disease, metabolism, cancer outcomes, and recovery from illness or surgery.

Low values usually reflect fewer platelets or proportionally more lymphocytes. In plain terms, this can signal lower clotting reserve or an active immune response, respectively. People may notice easy bruising if platelet counts are truly low (thrombocytopenia), while relative lymphocyte increases (lymphocytosis), often seen with viral infections, also lower PLR. Children naturally run lower PLR because lymphocyte counts are higher in early life.

Being in range suggests balanced hemostasis and immune tone, with neither excessive clotting drive nor suppressed lymphocyte presence. Most healthy individuals sit near the middle of laboratory reference intervals, aligning with stable cardio-metabolic risk signaling and resilient recovery capacity.

High values usually reflect too many platelets (thrombocytosis) or too few lymphocytes (lymphopenia). This pattern is common with systemic inflammation, physiological stress and cortisol surges, after surgery or trauma, in iron deficiency, and with some chronic cardiometabolic conditions. It marks a more prothrombotic, repair-focused state alongside relative adaptive immune downshift, a pattern that tends to become more frequent with aging and is sometimes higher in pregnancy due to relative lymphopenia.

FAQs

PLR testing uses values from a complete blood count—platelet count divided by lymphocyte count—to reflect inflammation–immune balance and clotting readiness.

Testing PLR offers a clear snapshot of systemic inflammatory load, adds context to cardiometabolic risk, helps track recovery from infections or surgery, and provides trendable data without an extra blood draw.

PLR is most useful when trended. Check it whenever a CBC is performed and compare results to your baseline over time.

Acute illness, chronic inflammation, iron status, nutrient deficiencies, medications (including glucocorticoids), smoking exposure, stress, intense training, and sleep debt can all influence PLR.

PLR is derived from a standard CBC. Follow the same preparation instructions that apply to your CBC.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Gasparyan, A. Y., Ayvazyan, L., Mukanova, U., Yessirkepov, M., & Kitas, G. D. (2019). The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Annals of Laboratory Medicine, 39(4), 345-357. https://doi.org/10.3343/alm.2019.39.4.345
  2. Li, W., Liu, Q., & Tang, Y. (2017). Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: A meta-analysis. Scientific Reports, 7, 40426. https://doi.org/10.1038/srep40426
  3. Guo, W., Lu, X., Liu, Q., Zhang, T., Li, P., Qiao, W., & Deng, M. (2019). Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Medicine, 8(9), 4135-4148. https://doi.org/10.1002/cam4.2281
  4. Islam, M. M., Satici, M. O., & Eroglu, S. E. (2024). Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turkish Journal of Emergency Medicine, 24(1), 8-19. https://doi.org/10.4103/tjem.tjem_198_23
  5. Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022). Beyond hemostasis: Platelet innate immune interactions and thromboinflammation. International Journal of Molecular Sciences, 23(7), 3868. https://doi.org/10.3390/ijms23073868

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey